Human Coronavirus 229E (Surrogate For COVID-19) Rapidly Eliminated By 3PRE-Activated Molybdenum, Lab Results Demonstrate

HINGHAM, Mass., May 10, 2020 /PRNewswire/ -- Advancing Medical Innovations (AMI) announced today lab results achieved by its client Performance Compounds Inside (PCI) demonstrating significant, rapid antimicrobial activity against human coronavirus 229E (a surrogate for COVID-19) using...

from PR Newswire: https://ift.tt/3cmBJOz